Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older […]
- Home
- IBD
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok